SilkRoad GoldenBridge Capital logo

SilkRoad GoldenBridge Capital

Asia, Guangdong, China, Futian

Description

SilkRoad GoldenBridge Capital operates as an investment firm.

Investor Profile

SilkRoad GoldenBridge Capital has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series B rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Asset Management, Big Data, Risk Management.
  • Led 1 rounds in the past year.

Stage Focus

  • Series Unknown (50%)
  • Series B (50%)

Country Focus

  • China (100%)

Industry Focus

  • Asset Management
  • Big Data
  • Risk Management
  • Software
  • Biotechnology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does SilkRoad GoldenBridge Capital frequently co-invest with?

Goldman Sachs
North America, New York, United States, New York
Co-Investments: 1
QF
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Empower Investment
Asia, Shanghai, China, Shanghai
Co-Investments: 1
PC
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Guangdong Yuecai Venture Capital Co., Ltd.
Asia, Guangdong, China, Guangzhou
Co-Investments: 1

What are some of recent deals done by SilkRoad GoldenBridge Capital?

Caihe Biology

Changhe, Guangxi, China

Caihe Biology is a pharmaceutical product development company specializing in the research formulation, and commercialization.

Medical
Series ASep 4, 2025
Dewo Intelligent

Kunshan, Anhui, China

Dewo Intelligent is an IoT solution provider focusing on identification and smart hardware.

HardwareInternet of Things
Series AAug 10, 2025
Silicon Ceramics New Energy

Daxing, Beijing, China

Silicon Ceramics New Energy is a manufactures synthetic quartz sand and silicon carbide, and offers chip thermal management solutions.

ChemicalManufacturingSemiconductor
AngelJul 22, 2025
Amount Raised: $1,394,272
Shanwan Bio

Suzhou, Jiangsu, China

Shanwan Bio is a comprehensive pharmaceutical company integrating drug research and development, production and sales.

BiotechnologyPharmaceutical
Series BApr 8, 2025
XunceTech

Shenzhen, Guangdong, China

XunceTech operates a risk management system and data management service provider.

Asset ManagementBig DataRisk ManagementSoftware
Series UnknownMar 1, 2021
Amount Raised: $15,311,330